sulfasalazine has been researched along with Mouth Neoplasms in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulfasalazine (SSZ) is an anti-inflammatory drug that has been used to treat inflammatory bowel disease and rheumatoid arthritis for decades." | 1.40 | Sulfasalazine induces autophagic cell death in oral cancer cells via Akt and ERK pathways. ( Han, HY; Jeong, SH; Kim, H; Lim, DS; Ryu, MH, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Q | 1 |
| Wang, X | 1 |
| Zhang, Y | 1 |
| Wang, L | 1 |
| Chen, Z | 1 |
| Han, HY | 1 |
| Kim, H | 1 |
| Jeong, SH | 1 |
| Lim, DS | 1 |
| Ryu, MH | 1 |
2 other studies available for sulfasalazine and Mouth Neoplasms
| Article | Year |
|---|---|
Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis.
Topics: Animals; Carboxypeptidases; Cell Line, Tumor; Cisplatin; Ferroptosis; Humans; Iron; Mice; Mouth Neop | 2022 |
Sulfasalazine induces autophagic cell death in oral cancer cells via Akt and ERK pathways.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Enzyme Activation | 2014 |